Edwards Lifesciences Corp (NYSE:EW) shares, rose in value, with the stock price down by -1.51% to the previous day’s close as strong demand from buyers drove the stock to $77.61.
Actively observing the price movement in the recent trading, the stock is buoying the session at $78.8, falling within a range of $77.05 and $78.385. The value of beta (5-year monthly) is 1.123 whereas the PE ratio is 51.85 over 12-month period. Referring to stock’s 52-week performance, its high was $95.25, and the low was $58.93. On the whole, EW has fluctuated by 2.39% over the past month.
With the market capitalization of Edwards Lifesciences Corp currently standing at about $45.53 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Apr-23.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 5.89B, with a low estimate of 1.45B and a high estimate of 1.51B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.49B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that EW’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 6.06, with the price of EW currently trading nearly 1.70% and 1.71% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 55.62, while the 7-day volatility ratio is showing 1.75% which for the 30-day chart, stands at 1.90%. Furthermore, Edwards Lifesciences Corp (EW)’s beta value is 1.08.
A comparison of Edwards Lifesciences Corp (EW) with its peers suggests the former has fared considerably weaker in the market. EW showed an intraday change of -1.51% in today’s session so far, and over the past year, it grew by 4.84%%.
Data on historical trading for Edwards Lifesciences Corp (NYSE:EW) indicates that the trading volumes over the past 10 days have averaged 3.39 and over the past 3 months, they’ve averaged 4.21 million. According to company’s latest data on outstanding shares, there are 586.20 million shares outstanding.
Nearly 2.03% of Edwards Lifesciences Corp’s shares belong to company insiders and institutional investors own 87.63% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 6.07 million shares as on 2025-06-13, resulting in a short ratio of 1.39. According to the data, the short interest in Edwards Lifesciences Corp (EW) stood at 118.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 7.38 million. The stock has fallen by -16.98% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the EW stock heading into the next quarter.
